Patient reported outcomes (PROs) analysis for patients with ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC) receiving entrectinib in the global phase II STARTRK-2 study Meeting Abstract
| Authors: | Barlesi, F.; Wolf, J.; Ahn, M. J.; Doebele, R. C.; Paz-Ares, L.; Rolfo, C.; Siena, S.; Seto, T.; Ohe, Y.; Ou, S. H. I.; Krebs, M. G.; Kapre, A.; Piault-Louis, E.; McCallum, S.; Osborne, S.; Aziez, A.; Drilon, A. |
| Abstract Title: | Patient reported outcomes (PROs) analysis for patients with ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC) receiving entrectinib in the global phase II STARTRK-2 study |
| Meeting Title: | ESMO Asia Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2020 Nov 20-22 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | S1391 |
| End Page: | S1392 |
| Language: | English |
| ACCESSION: | WOS:000600988900389 |
| DOI: | 10.1016/j.annonc.2020.10.379 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 385P -- Source: Wos |
